Link: https://nationalfile.com/pfizer-stock-forecasts-die-down-suddenly-as-demand-for-covid-products-drop/
Pfizer anticipates demand is faltering due to "fewer people" being "expected to receive their primary doses." | The pharmaceutical giant has witnessed its stock outlook falter going into 2023. Pfizer Inc shares have fallen 15% over the past month, eliminating a whopping $43 billion from the stock’s market cap. The company forecasted Tuesday it will only make $13.5 billion in vaccine sales this year, which marks a 64 percent drop from 2022. Analysts had previously predicted the forecast would amount to $16 billion, according to Zerohedge.